Literature DB >> 17138556

Crystal structure of human inosine triphosphatase. Substrate binding and implication of the inosine triphosphatase deficiency mutation P32T.

Pål Stenmark1, Petri Kursula, Susanne Flodin, Susanne Gräslund, Robert Landry, Pär Nordlund, Herwig Schüler.   

Abstract

Inosine triphosphatase (ITPA) is a ubiquitous key regulator of cellular non-canonical nucleotide levels. It breaks down inosine and xanthine nucleotides generated by deamination of purine bases. Its enzymatic action prevents accumulation of ITP and reduces the risk of incorporation of potentially mutagenic inosine nucleotides into nucleic acids. Here we describe the crystal structure of human ITPA in complex with its prime substrate ITP, as well as the apoenzyme at 2.8 and 1.1A, respectively. These structures show for the first time the site of substrate and Mg2+ coordination as well as the conformational changes accompanying substrate binding in this class of enzymes. Enzyme substrate interactions induce an extensive closure of the nucleotide binding grove, resulting in tight interactions with the base that explain the high substrate specificity of ITPA for inosine and xanthine over the canonical nucleotides. One of the dimer contact sites is made up by a loop that is involved in coordinating the metal ion in the active site. We predict that the ITPA deficiency mutation P32T leads to a shift of this loop that results in a disturbed affinity for nucleotides and/or a reduced catalytic activity in both monomers of the physiological dimer.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17138556     DOI: 10.1074/jbc.M609838200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  18 in total

1.  Functional study of the P32T ITPA variant associated with drug sensitivity in humans.

Authors:  Elena I Stepchenkova; Elena R Tarakhovskaya; Kathryn Spitler; Christin Frahm; Miriam R Menezes; Peter D Simone; Carol Kolar; Luis A Marky; Gloria E O Borgstahl; Youri I Pavlov
Journal:  J Mol Biol       Date:  2009-07-23       Impact factor: 5.469

Review 2.  Modulation of mutagenesis in eukaryotes by DNA replication fork dynamics and quality of nucleotide pools.

Authors:  Irina S-R Waisertreiger; Victoria G Liston; Miriam R Menezes; Hyun-Min Kim; Kirill S Lobachev; Elena I Stepchenkova; Tahir H Tahirov; Igor B Rogozin; Youri I Pavlov
Journal:  Environ Mol Mutagen       Date:  2012-10-10       Impact factor: 3.216

3.  Association of ITPA gene polymorphisms with adverse effects of AZA/6-MP administration: a systematic review and meta-analysis.

Authors:  Evaggelia Barba; Panagiota I Kontou; Ioannis Michalopoulos; Pantelis G Bagos; Georgia G Braliou
Journal:  Pharmacogenomics J       Date:  2022-01-17       Impact factor: 3.550

4.  Structural and functional characterization of a noncanonical nucleoside triphosphate pyrophosphatase from Thermotoga maritima.

Authors:  Khaldeyah Awwad; Anna Desai; Clyde Smith; Monika Sommerhalter
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2013-01-18

5.  The human ITPA polymorphic variant P32T is destabilized by the unpacking of the hydrophobic core.

Authors:  Peter D Simone; Lucas R Struble; Admir Kellezi; Carrie A Brown; Corinn E Grabow; Irine Khutsishvili; Luis A Marky; Youri I Pavlov; Gloria E O Borgstahl
Journal:  J Struct Biol       Date:  2013-03-23       Impact factor: 2.867

6.  Overexpression of HAM1 gene detoxifies 5-bromodeoxyuridine in the yeast Saccharomyces cerevisiae.

Authors:  Shinichi Takayama; Michihiko Fujii; Aya Kurosawa; Noritaka Adachi; Dai Ayusawa
Journal:  Curr Genet       Date:  2007-09-27       Impact factor: 3.886

7.  Genetic polymorphism of inosine triphosphate pyrophosphatase is a determinant of mercaptopurine metabolism and toxicity during treatment for acute lymphoblastic leukemia.

Authors:  G Stocco; M H Cheok; K R Crews; T Dervieux; D French; D Pei; W Yang; C Cheng; C-H Pui; M V Relling; W E Evans
Journal:  Clin Pharmacol Ther       Date:  2008-08-06       Impact factor: 6.875

8.  Quantitative in vitro and in vivo characterization of the human P32T mutant ITPase.

Authors:  Greg Herting; Katie Barber; Maria R Zappala; Richard P Cunningham; Nicholas E Burgis
Journal:  Biochim Biophys Acta       Date:  2009-11-13

Review 9.  A disease spectrum for ITPA variation: advances in biochemical and clinical research.

Authors:  Nicholas E Burgis
Journal:  J Biomed Sci       Date:  2016-10-22       Impact factor: 8.410

10.  GLiMMPS: robust statistical model for regulatory variation of alternative splicing using RNA-seq data.

Authors:  Keyan Zhao; Zhi-xiang Lu; Juw Won Park; Qing Zhou; Yi Xing
Journal:  Genome Biol       Date:  2013-07-22       Impact factor: 13.583

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.